Literature DB >> 14959693

Quality of life and HIV: current assessment tools and future directions for clinical practice.

Howard A Grossman1, Patrick S Sullivan, Albert W Wu.   

Abstract

Routine clinical assessment of health-related quality of life in persons with HIV infection has the potential to improve care by assessing and monitoring treatment effects, enhancing communication between patient and provider, and tracking changes in functional status over time. Currently available research-based assessment tools may be inadequate for routine clinical use because of the lack of inclusion of HIV-relevant aspects of quality of life and the impracticality of the use of such tools in the clinical setting. There may be a need for a new, clinically relevant, HIV-specific assessment tool that would be easy to incorporate into clinical practice to briefly, yet comprehensively, assess characteristics frequently found in HIV-infected persons, such as fatigue, pain, nausea and vomiting, sleep disturbances, sexual dysfunction, and body image issues. Until such a tool is developed, the Linear Analogue Self-Assessment questionnaire and the Medical Outcomes Study Short Form-12 (MOS SF-12) are short enough for routine use in a clinical setting. Slightly longer measures, such as the MOS-HIV Health Survey (MOS-HIV), can provide information in a greater number of domains.

Entities:  

Mesh:

Year:  2003        PMID: 14959693

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  21 in total

1.  Psychometric evaluation of the functional assessment of HIV Infection (FAHI) questionnaire and its usefulness in clinical trials.

Authors:  Muriel Viala-Danten; Dominique Dubois; Hélène Gilet; Silas Martin; Katrien Peeters; David Cella
Journal:  Qual Life Res       Date:  2010-05-28       Impact factor: 4.147

Review 2.  A Review of HIV-Specific Patient-Reported Outcome Measures.

Authors:  Kim Engler; David Lessard; Bertrand Lebouché
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

3.  Change in quality of life after being diagnosed with HIV: a multicenter longitudinal study.

Authors:  Joel Tsevat; Anthony C Leonard; Magdalena Szaflarski; Susan N Sherman; Sian Cotton; Joseph M Mrus; Judith Feinberg
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

4.  Sleep, function and HIV: a multi-method assessment.

Authors:  Charlene E Gamaldo; Adam P Spira; Rebecca S Hock; Rachel E Salas; Justin C McArthur; Paula M David; Gilbert Mbeo; Michael T Smith
Journal:  AIDS Behav       Date:  2013-10

5.  Health-Related Quality of Life and Living Costs of HIV-Infected Patients.

Authors:  Pantelis Stergiannis; Eydokia Rapti; Georgios Boulmetis; Charalampos Platis; Christina Stergianni; George Intas
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Health-related quality of life assessment after antiretroviral therapy: a review of the literature.

Authors:  Harleen Gakhar; Amanda Kamali; Mark Holodniy
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

Review 7.  Sociodemographic differences in quality of life in rheumatoid arthritis.

Authors:  Erik J Groessl; Theodore G Ganiats; Andrew J Sarkin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

8.  Evaluating sleep and cognition in HIV.

Authors:  Charlene E Gamaldo; Alyssa Gamaldo; Jason Creighton; Rachel E Salas; Ola A Selnes; Paula M David; Gilbert Mbeo; Benjamin S Parker; Amanda Brown; Justin C McArthur; Michael T Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

9.  Gender Differences in Health Related Quality of Life of People Living with HIV/AIDS in the Era of Highly Active Antiretroviral Therapy.

Authors:  Easwaran Vigneshwaran; Yiragam Padmanabhareddy; Nayakanti Devanna; Gerardo Alvarez-Uria
Journal:  N Am J Med Sci       Date:  2013-02

10.  Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients.

Authors:  Bach Xuan Tran; Arto Ohinmaa; Long Thanh Nguyen
Journal:  Health Qual Life Outcomes       Date:  2012-11-01       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.